科拓生物(300858.SZ)：上半年净利润4120.51万元 同比下降5.31%

Group 1 - The core viewpoint of the article is that Keta Bio (300858.SZ) reported its 2025 semi-annual results, showing a mixed performance with revenue growth but a decline in net profit [1] Group 2 - The company achieved an operating income of 163 million yuan in the first half of the year, representing an 18.32% year-on-year increase [1] - The net profit attributable to shareholders of the listed company was 41.21 million yuan, reflecting a 5.31% year-on-year decrease [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 35.13 million yuan, down 6.67% year-on-year [1] - The basic earnings per share were 0.16 yuan [1]